Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.14% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBPX
1326
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $9.25M | 0.01% |
396,813
-99,887
| -20% | -$2.42M |
|
|
AMRN
1327
Amarin Corp
AMRN
$287M
| $9.23M | 0.01% |
114,534
+28,024
| +32% | +$1.74M |
|
|
BFIN
1328
DELISTED
BankFinancial
BFIN
| $9.22M | 0.01% |
617,800
+63,500
| +11% | +$939K |
|
|
OKSB
1329
DELISTED
Southwest Bancorp Inc/OK
OKSB
| $9.2M | 0.01% |
359,933
+54,000
| +18% | +$1.37M |
|
1330
BancFirst
BANF
$3.91B
| $9.19M | 0.01% |
190,200
-3,400
| -2% | -$161K |
|
1331
NOV
NOV
$7.27B
| $9.18M | 0.01% |
278,610
-74,700
| -21% | -$2.58M |
|
1332
Hexcel
HXL
$8.1B
| $9.17M | 0.01% |
+173,700
| New | +$8.98M |
|
1333
Avista
AVA
$3.49B
| $9.16M | 0.01% |
215,800
+110,900
| +106% | +$4.63M |
|
|
RAS
1334
DELISTED
RAIT Financial Trust
RAS
| $9.15M | 0.01% |
4,178,700
+15,600
| +0.4% | +$40.1K |
|
1335
Horizon Bancorp
HBNC
$1.05B
| $9.14M | 0.01% |
520,542
+85,437
| +20% | +$1.48M |
|
|
LHCG
1336
DELISTED
LHC Group LLC
LHCG
| $9.12M | 0.01% |
134,400
-7,100
| -5% | -$424K |
|
|
STS
1337
DELISTED
Supreme Industries Inc Class A
STS
| $9.04M | 0.01% |
549,378
+172,275
| +46% | +$3.18M |
|
|
DCH
1338
Dauch Corp
DCH
$1.3B
| $9M | 0.01% |
+577,199
| New | +$9.4M |
|
|
CCN
1339
DELISTED
CardConnect Corp.
CCN
| $8.99M | 0.01% |
597,640
+463,061
| +344% | +$6.63M |
|
|
CSOD
1340
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $8.99M | 0.01% |
251,500
+235,700
| +1,492% | +$8.83M |
|
1341
Middleby
MIDD
$6.21B
| $8.99M | 0.01% |
+73,970
| New | +$9.77M |
|
|
STB
1342
DELISTED
Student Transportation Inc
STB
| $8.98M | 0.01% |
1,480,800
-4,871
| -0.3% | -$28.9K |
|
|
CSII
1343
DELISTED
Cardiovascular Systems, Inc.
CSII
| $8.97M | 0.01% |
278,301
+219,501
| +373% | +$6.69M |
|
1344
Powell Industries
POWL
$7.57B
| $8.93M | 0.01% |
837,300
+41,400
| +5% | +$460K |
|
|
WMC
1345
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $8.92M | 0.01% |
86,571
+28,380
| +49% | +$2.91M |
|
1346
Pinnacle West Capital
PNW
$13B
| $8.91M | 0.01% |
104,600
-216,100
| -67% | -$18.6M |
|
1347
Itaú Unibanco
ITUB
$92.4B
| $8.9M | 0.01% |
1,660,634
-3,231,292
| -66% | -$18.1M |
|
1348
Employers Holdings
EIG
$924M
| $8.9M | 0.01% |
210,300
+7,200
| +4% | +$289K |
|
1349
BlackLine
BL
$1.85B
| $8.88M | 0.01% |
248,400
+157,605
| +174% | +$5.22M |
|
|
MRSH
1350
Marsh
MRSH
$90.6B
| $8.86M | 0.01% |
113,700
-190,500
| -63% | -$14.4M |
|
Similar funds
Renaissance Technologies's Q2 2017 Portfolio in Review
As of Q2 2017, Renaissance Technologies held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Renaissance Technologies deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Renaissance Technologies's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Renaissance Technologies's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Renaissance Technologies fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Renaissance Technologies's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Renaissance Technologies opened 398 new positions and closed 418 in Q2 2017.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.